FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology. Diagnostic method for in vitro diagnosis of endometrial cancer is disclosed. Method involves determining level of P4HB biomarker in sample from patient. It has been found that differential expression of this biomarker in tumour tissue of primary endometrial cancer correlates with its expression level in uterine liquid samples in comparison with reference values. So biomarker is demonstrative, since it has been found that it differentially expresses in several different types of samples from affected beings.
EFFECT: invention can be used in medicine.
54 cl, 20 dwg, 12 tbl, 25 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR EVALUATING RISK OF ENDOMETRIAL CANCER | 2014 |
|
RU2558059C1 |
| COMPOSITIONS, DIAGNOSTIC TECHNIQUES AND METHOD OF TREATING RENAL DISORDERS IN DOGS | 2010 |
|
RU2546016C2 |
| DIAGNOSTIC TECHNIQUE AND KIT FOR DIAGNOSING GLOMERULONEPHITIS IN CAT | 2011 |
|
RU2564122C2 |
| BIOMARKER | 2009 |
|
RU2573925C2 |
| METHOD FOR DIAGNOSING COLORECTAL CANCER FROM HUMAN FECES SAMPLE BY QUANTITATIVE PCR, PRIMERS AND KIT | 2015 |
|
RU2692555C2 |
| BIOMARKER PANEL AND METHODS FOR DETECTING MICROSATELLITE INSTABILITY IN VARIOUS TYPES OF CANCER | 2019 |
|
RU2795410C2 |
| URINE BIOMARKER COHORTS, GENE EXPRESSION SIGNATURES AND METHODS OF USE THEREOF | 2014 |
|
RU2668164C2 |
| ANTI-PD-L1 ANTIBODIES AND METHODS FOR THEIR DIAGNOSTIC USE | 2015 |
|
RU2715038C2 |
| TREATMENT OF SIRTUIN (SIRT) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO SIRTUIN (SIRT) | 2011 |
|
RU2693462C2 |
| PHOSPHODIESTERASE 4D7 AS PROSTATE CANCER MARKER | 2010 |
|
RU2651474C2 |
